Falcone, I.; Giontella, E.; Giuliani, S.; Borghesani, G.; Valenti, A.; Zambonin, V.; Monteverdi, S.; Carbognin, L.; Bria, E.; Ciuffreda, L.;
et al. HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations. Int. J. Mol. Sci. 2025, 26, 6593.
https://doi.org/10.3390/ijms26146593
AMA Style
Falcone I, Giontella E, Giuliani S, Borghesani G, Valenti A, Zambonin V, Monteverdi S, Carbognin L, Bria E, Ciuffreda L,
et al. HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations. International Journal of Molecular Sciences. 2025; 26(14):6593.
https://doi.org/10.3390/ijms26146593
Chicago/Turabian Style
Falcone, Italia, Elena Giontella, Stefano Giuliani, Giulia Borghesani, Alessandro Valenti, Valentina Zambonin, Sara Monteverdi, Luisa Carbognin, Emilio Bria, Ludovica Ciuffreda,
and et al. 2025. "HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations" International Journal of Molecular Sciences 26, no. 14: 6593.
https://doi.org/10.3390/ijms26146593
APA Style
Falcone, I., Giontella, E., Giuliani, S., Borghesani, G., Valenti, A., Zambonin, V., Monteverdi, S., Carbognin, L., Bria, E., Ciuffreda, L., Conciatori, F., Bazzichetto, C., Pedron, S., Nottegar, A., Zanelli, S., Muzzarelli, A., Fabi, A., Migliaccio, S., Ferretti, E.,
... Milella, M.
(2025). HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations. International Journal of Molecular Sciences, 26(14), 6593.
https://doi.org/10.3390/ijms26146593